Skip to content

Abnormal Circulating Homocysteine Concentration C4023651

Published: July 22, 2026Updated: August 20, 2026

Homocysteine is an amino acid that at high levels may increase heart disease risk. It can rise due to genetic factors or B vitamin deficiencies. Treatment often involves dietary changes and supplementation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Increased blood clot risk

Elevated risk of abnormal blood clot formation that can lead to deep vein thrombosis or pulmonary embolism.

EMERGENCY: Seek immediate care for sudden shortness of breath, chest pain, or leg swelling/redness.

!

Chest pain or discomfort

Angina-like chest pain that may indicate increased cardiovascular strain.

EMERGENCY: Chest pain requires immediate medical evaluation to rule out cardiac events.

Persistent fatigue and weakness

(constitutional)

Generalized tiredness and lack of energy that persists despite adequate rest.

Frequency: 70-80% of patients

Cognitive difficulties and memory problems

(neurologic)

Trouble with concentration, memory recall, and mental clarity.

Frequency: 50-60% of patients

Numbness and tingling sensations

(neurologic)

Paresthesia (pins and needles sensation) often in hands and feet due to nerve involvement.

Frequency: 40-50% of patients

Skin changes and lesions

(dermatologic)

Rash, skin discoloration, or eczema-like patches, particularly on sun-exposed areas.

Frequency: 15-25% of patients

Difficulty with balance and gait

(neurologic)

Unsteady walking, balance problems, or coordination difficulties.

Frequency: 10-15% of patients

Vision disturbances

(neurologic)

Blurred vision or other visual changes related to optic nerve involvement.

Frequency: 5-10% of patients

Unexplained weight loss

(gastrointestinal)

Significant unintentional weight loss without changes in diet or exercise.

Frequency: 5-10% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

B-vitamin supplementation

Folic acid, vitamin B12, and vitamin B6 supplementation to address common causes of hyperhomocysteinemia. These cofactors are essential for homocysteine metabolism and clearance.

medication
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Folate-rich food intake

Increased consumption of folate-dense foods including leafy green vegetables, legumes, avocados, and fortified grains. Dietary folate supports normal homocysteine metabolism.

dietary

Additional treatment options

Smoking cessation

Complete cessation of tobacco use as smoking significantly elevates homocysteine levels and impairs B-vitamin metabolism. Cessation improves cardiovascular risk profile.

lifestyle

Moderate physical activity

Regular aerobic exercise improves endothelial function and can help lower homocysteine levels. Exercise enhances overall cardiovascular health and supports methyl-group metabolism.

lifestyle

Cardiovascular risk stratification

Comprehensive assessment including homocysteine levels, lipid profile, blood pressure, and diabetes screening. Elevated homocysteine indicates increased cardiovascular and thrombotic risk.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Homocysteine Concentration C4023651?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 2019;50:e344–e418.

guideline2019View source →
2

Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315-2381.

guideline2016View source →
3

Martí-Carvajal AJ, Solà I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;1:CD006612.

meta_analysis2017View source →
4

O'Neill C, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1-12.

review2015View source →
5

American College of Medical Genetics and Genomics. Clinical utility of genetic testing in disorders of sulfur metabolism. ACMG Technical Standards and Guidelines. 2019.

guideline2019View source →
6

Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med. 1995;332:328-329.

position_statement1995View source →
7

Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B12 and folate. Clin Chem. 2000;46:1277-1283.

review2000View source →
8

National Institutes of Health Consensus Development Panel. Homocysteine, B vitamins, and cardiovascular disease. JAMA. 1998;280:2008-2014.

consensus1998View source →
9

Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015-2022.

meta_analysis2002View source →
10

Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:2007-2056.

textbook2001

Medication Comparisons

Compare medications used to treat Abnormal Circulating Homocysteine Concentration C4023651. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy